According to a new report published by Allied Market Research, titled, "Contrast Injector Systems Market," The contrast injector systems market was valued at $755.57 million in 2020, and is estimated to reach $1.5 billion by 2030, growing at a CAGR of 7.3% from 2021 to 2030.
Contrast injector system is a medical diagnostic device that uses a contrast medium to create visual representations of the human body's interior to diagnose, monitor, or treat clinical problems. Computed tomography, magnetic resonance imaging, and angiography are three of the most common imaging procedures. When compared to typical image processing, the contrast media improves the contrast structures or visibility of fluids within the body. It is utilized to make blood vessels and the gastrointestinal tract more visible.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/3977
North America accounted for more than 7.5% of the global market share in 2020, and is expected to remain dominant during the forecast period. This was attributed to the research activities for contrast injector system, which are soaring in North America, owing to the well-established healthcare facilities, recent technological advancements, and rise in demand for early diagnosis of chronic diseases due to increase in awareness regarding contrast injectors. Asia-Pacific is projected to register the highest CAGR of 8.1% during the forecast period, owing to increase in incidence of population suffering from various chronic diseases, such as cancer, heart diseases, Alzheimer's, and dementia and rise in ageing population. In addition, increase in healthcare expenditure offers a lucrative opportunity for the contrast injector systems market share.
KEY FINDINGS OF STUDY
By product type, the consumables segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 7.2% from 2021 to 2030.
By application, interventional radiology is projected to grow at a CAGR of 7.0% during the forecast period.
By end user, the hospital segment is expected to experience growth at the highest rate, registering a CAGR of 7.4% during the forecast period.
Region-wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 8.1% during the forecast period.
Increase in imaging procedures, owing to the rapid incidence of various chronic diseases, such as cancer, heart diseases, Alzheimer's, and dementia is expected to drive the contrast injector systems market size. In addition, rise in increase in geriatric population and high prevalence of chronic diseases globally, boost the market growth. However, high cost of contrast injectors systems and high risk associated with contrast injector systems are expected to impede the growth in contrast injector systems market forecast. Moreover, surge in healthcare expenditure and emergence of complex diseases in developing countries are expected to create lucrative opportunities for key market player and driving the contrast injector systems industry.
Key Market Segments
By Product Type
Consumables
Injector Systems
Accessories
By Application
Radiology
Interventional Radiology
Interventional Cardiology
By End User
Clinics
Others
Hospitals
Diagnostics centers
Key Market Players
Bracco Imaging S.p.A
bayer healthcare
Guerbet Group
Medtron AG
Ulrich GmbH & Co. KG
GE Healthcare
Shenzhen Seacrown Electromechanical Co., Ltd.
Nemoto Kyorindo Co. Ltd.
Sino Medical- Device Technology Co., Ltd.
Vivid Imaging
Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4153
